Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.
Pancreatic cancer statistics
New cases of pancreatic cancer, 2014, UK
Deaths from pancreatic cancer, 2014, UK
Survive pancreatic cancer for 10 or more years, 2010-11, England and Wales
Preventable cases of pancreatic cancer, UK
- There were around 9,600 new cases of pancreatic cancer in the UK in 2014, that’s 26 cases diagnosed every day.
- Pancreatic cancer is the 11th most common cancer in the UK (2014).
- Pancreatic cancer accounts for 3% of all new cases in the UK (2014).
- In males in the UK, pancreatic cancer is the 12th most common cancer, with around 4,800 cases diagnosed in 2014.
- In females in the UK, pancreatic cancer is the ninth most common cancer, with around 4,800 cases diagnosed in 2014.
- Almost half (47%) of pancreatic cancer cases in the UK each year are diagnosed in people aged 75 and over (2012-2014).
- Incidence rates for pancreatic cancer in the UK are highest in people aged 85+ (2012-2014).
- Since the late 1970s, pancreatic cancer incidence rates remained stable in Great Britain. However this overall pattern masks increased rates in females (13%, more than a tenth), and decreased rates in males (10%, a tenth).
- Over the last decade, pancreatic cancer incidence rates have increased by a tenth (10%) in the UK, with a slightly larger increase in females (11%) than in males (8%).
- Around 8 in 10 pancreatic cancer cases are diagnosed at a late stage in England (2014) and Northern Ireland (2010-2014).
- Incidence rates for pancreatic cancer are projected to rise by 6% in the UK between 2014 and 2035, to 21 cases per 100,000 people by 2035.
- 1 in 71 people will be diagnosed with pancreatic cancer during their lifetime.
- Pancreatic cancer in England is more common in people living in the most deprived areas.
- Pancreatic cancer is more common in White and Black people than in Asian people.
- In the UK around 4,300 people were still alive at the end of 2006, up to ten years after being diagnosed with pancreatic cancer.
- In Europe, around 104,000 new cases of pancreatic cancer were estimated to have been diagnosed in 2012. The UK incidence rate is eighth lowest in Europe for males and 20th highest for females.
- Worldwide, around 338,000 people were estimated to have been diagnosed with pancreatic cancer in 2012, with incidence rates varying across the world.
- There were around 8,800 pancreatic cancer deaths in the UK in 2014, that’s 24 deaths every day.
- Pancreatic cancer is the fifth most common cause of cancer death in the UK (2014).
- Pancreatic cancer accounts for 5% of all cancer deaths in the UK (2014).
- In males in the UK, pancreatic cancer is the fifth most common cause of cancer death, with around 4,400 deaths in 2014.
- In females in the UK, pancreatic cancer is the fourth most common cause of cancer death, with around 4,400 deaths in 2014.
- Since the late 1970s, pancreatic cancer mortality rates remained stable in the UK. However, this overall pattern masks increased rates in females (12%) and decreased rates in males (14%).
- Over the last decade, pancreatic cancer mortality rates have increased by less than a tenth (7%) in the UK. The increase is similar in males (6%) and females (7%).
- Mortality rates for pancreatic cancer are projected to fall by 3% in the UK between 2014 and 2035, to 17 deaths per 100,000 people by 2035
- Pancreatic cancer deaths in England are more common in people living in the most deprived areas.
- In Europe, more than 104,000 people were estimated to have died from pancreatic cancer in 2012. The UK mortality rate is fifth lowest in Europe for males and 17th lowest for females.
- Worldwide, more than 330,000 people were estimated to have died from pancreatic cancer in 2012, with mortality rates varying across the world.
- Only 1% of people diagnosed with pancreatic cancer in England and Wales survive their disease for ten years or more (2010-11).
- Less than 5 in 100 (3%) of people diagnosed with pancreatic cancer in England and Wales survive their disease for five years or more (2010-11).
- Around a fifth (21%) of people diagnosed with pancreatic cancer in England and Wales survive their disease for one year or more (2010-11).
- Pancreatic cancer survival is similar in men than women.
- Pancreatic cancer survival in England is higher for people diagnosed aged under 50 years old (2009-2013).
- More than 3 in 20 men and around a quarter of women in England diagnosed with pancreatic cancer aged 15-49 survive their disease for five years or more, compared with only 2% of people diagnosed aged 80 and over (2009-2013).
- Pancreatic cancer survival has not shown much improvement in the last 40 years in the UK.
- In the 1970s, 1% of people diagnosed with pancreatic cancer survived their disease beyond ten years, now it's still 1%.
- Five-year relative survival for pancreatic cancer in men is below the European average in England, Wales, Scotland and Northern Ireland.
- Five-year relative survival for pancreatic cancer in women is below the European average in England but similar to the European average in Wales.
- A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
- 37% of pancreatic cancer cases each year in the UK are linked to major lifestyle and other risk factors.
- Smoking is the main avoidable risk factor for pancreatic cancer, linked to an estimated 29% of pancreatic cancer cases in the UK.
- An estimated 37% of pancreatic cancers in the UK are linked to lifestyle factors including smoking, and overweight and obesity (12%).
- Smokeless tobacco causes pancreatic cancer.
- Physical activity, fruits, and foods containing folate may relate to lower pancreatic cancer risk, but evidence is unclear.
- Alcohol, red meat, ionising radiation, and certain medical conditions and infections may relate to higher pancreatic cancer risk, but evidence is unclear.
- 'Emergency presentation' is the most common route to diagnosing pancreatic cancer.
- ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland, and ‘62-day wait’ is not met by any country for upper gastrointestinal cancers.
- Almost a tenth of pancreatic cancer patients receive major surgical resection as part of their cancer treatment.
- Almost 9 in 10 patients had a ‘very good’ or ‘excellent’ patient experience.
- Almost 9 in 10 patients are given the name of their Clinical Nurse Specialist.
The latest statistics available for pancreatic cancer in the UK are; incidence 2014, mortality 2014 and survival 2010-2011 (all ages combined) and 2009-2013 (by age).
European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.
Lifetime risk estimates were calculated using incidence, mortality, population and all-cause mortality data for 2012.
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages,
Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2012-2013.
Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Pancreatic cancer is part of the group 'Upper Gastrointestinal cancer' for cancer waiting times data. Codes vary per country but broadly include: oesophagus, stomach, liver, gallbladder, other and unspecified parts of biliary tract, pancreas, secondary cancers of liver, intrahepatic bile duct and duodenum.
Cancer surgical resection rates data is for patients diagnosed in England between 2006 and 2010.
Patient Experience data is for adult patients in England with a primary diagnosis of cancer, who were in active treatment between September and November 2013 and who completed a survey in 2014.
Deprivation gradient statistics were calculated using incidence data for three time periods: 1996-2000, 2001-2005 and 2006-2010 and for mortality for two time periods: 2002-2006 and 2007-2011. The 1997-2001 mortality data were only used for the all cancers combined group as this time period includes the change in coding from ICD-9 to ICD-10. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.
You are welcome to reuse this Cancer Research UK statistics content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.
When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or